Publications by authors named "P Glaziou"
Background: Coronavirus disease-2019 (COVID-19) pandemic has deeply impacted tuberculosis (TB) services globally. This study aims to assess the COVID-19 pandemic's impact on TB diagnosis and care and explore associated factors in the Western Pacific Region.
Methods: We analysed TB case notifications and treatment outcomes for the Region and 14 selected countries and areas from 2015 to 2022.
Article Synopsis
- - This study investigates the prevalence of hepatitis B virus (HBV) in French Polynesia, where HBV infection significantly increases the risk of hepatocellular carcinoma (HCC), especially in the Austral archipelago, known for its high detection rates.
- - Blood samples from nearly 2,000 adults were tested, revealing that 1.0% were carriers of HBV, with higher rates found specifically in certain areas like the Austral and Marquesas archipelagos. Factors such as location, age, and education level influenced HBV carriage.
- - Although French Polynesia generally shows low HBV endemicity and low risk for hepatitis C and delta infections, the findings highlight a need for improved detection and prevention efforts, especially
Tuberculosis (TB) killed more people globally than any other single pathogen over the past decade. Where surveillance is weak, estimating TB burden estimates uses modeling. In many African countries, increases in HIV prevalence and antiretroviral therapy have driven dynamic TB epidemics, complicating estimation of burden, trends, and potential intervention impact.
View Article and Find Full Text PDFTuberculosis is second only to COVID-19 as a cause of death from a single infectious agent. In 2020, almost 10 million people were estimated to have developed tuberculosis and it caused 1·5 million deaths. Around a quarter of deaths caused by antimicrobial resistance are due to rifampicin-resistant tuberculosis.
View Article and Find Full Text PDF